Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/34736
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Adriaenssens, Niels | - |
dc.contributor.author | BRUYNDONCKX, Robin | - |
dc.contributor.author | Versporten, Ann | - |
dc.contributor.author | HENS, Niel | - |
dc.contributor.author | Monnet, Dominique L. | - |
dc.contributor.author | MOLENBERGHS, Geert | - |
dc.contributor.author | Goossens, Herman | - |
dc.contributor.author | Weist, Klaus | - |
dc.contributor.author | Coenen, Samuel | - |
dc.date.accessioned | 2021-08-30T12:56:40Z | - |
dc.date.available | 2021-08-30T12:56:40Z | - |
dc.date.issued | 2021 | - |
dc.date.submitted | 2021-08-30T08:44:10Z | - |
dc.identifier.citation | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (Supplement_2) , p. 37 -44 | - |
dc.identifier.uri | http://hdl.handle.net/1942/34736 | - |
dc.description.abstract | Objectives: Data on quinolone consumption in the community were collected from 30 EU/European Economic Area (EEA) countries over two decades. This article reviews temporal trends, seasonal variation, presence of change-points and changes in the composition of main subgroups of quinolones. Methods: For the period 1997-2017, data on consumption of quinolones, i.e. ATC group J01M, in the community and aggregated at the level of the active substance, were collected using the WHO ATC/DDD methodology (ATC/DDD index 2019). Consumption was expressed in DDD per 1000 inhabitants per day and in packages per 1000 inhabitants per day. Quinolone consumption was analysed by subgroups based on pharmacokinetic profile, and presented as trends, seasonal variation, presence of change-points and compositional changes. Results:In 2017, quinolone consumption in the community expressed in DDD per 1000 inhabitants per day varied by a factor of 8.2 between countries with the highest (Bulgaria) and the lowest (Norway) consumption. The second-generation quinolones accounted for >50% of quinolone consumption in most countries. Quinolone consumption significantly increased up to 2001, and did not change significantly afterwards. Seasonal variation increased significantly over time. Proportional consumption of third-generation quinolones significantly increased over time relative to that of second-generation quinolones, while proportional consumption of both third- and second-generation quinolones significantly increased relative to that of first-generation quinolones. Levofloxacin and moxifloxacin represented >40% of quinolone consumption in the community in southern EU/EEA countries. Conclusions: Quinolone consumption in the community is no longer increasing in the EU/EEA, but its seasonal variation continues to increase significantly as is the proportion of quinolones to treat respiratory infections. | - |
dc.description.sponsorship | Research Foundation-Flanders (FWO)FWO [12I6319N]; University of Antwerp scientific chair in Evidence-Based Vaccinology - Pfizer; University of Antwerp scientific chair in Evidence-Based Vaccinology - GSK; Flemish Government; European Commission | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.rights | VC The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | - |
dc.title | Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017 | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 44 | - |
dc.identifier.issue | Supplement_2 | - |
dc.identifier.spage | 37 | - |
dc.identifier.volume | 76 | - |
local.format.pages | 8 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Adriaenssens, N (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Antwerp, Belgium.; Adriaenssens, N (corresponding author), Univ Antwerp, Ctr Gen Practice, Dept Family Med & Populat Hlth FAMPOP, Antwerp, Belgium. | - |
dc.description.notes | niels.adriaenssens@uantwerpen.be | - |
local.publisher.place | GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1093/jac/dkab176 | - |
dc.identifier.isi | WOS:000684146500007 | - |
dc.contributor.orcid | Coenen, Samuel/0000-0002-1238-8052; Bruyndonckx, | - |
dc.contributor.orcid | Robin/0000-0002-4217-2869; Adriaenssens, Niels/0000-0002-7957-1177 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [Adriaenssens, Niels; Bruyndonckx, Robin; Versporten, Ann; Goossens, Herman; Coenen, Samuel] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Antwerp, Belgium. | - |
local.description.affiliation | [Adriaenssens, Niels; Coenen, Samuel] Univ Antwerp, Ctr Gen Practice, Dept Family Med & Populat Hlth FAMPOP, Antwerp, Belgium. | - |
local.description.affiliation | [Bruyndonckx, Robin; Hens, Niel; Molenberghs, Geert] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BIOST, Data Sci Inst, Hasselt, Belgium. | - |
local.description.affiliation | [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO, Antwerp, Belgium. | - |
local.description.affiliation | [Monnet, Dominique L.; Weist, Klaus] European Ctr Dis Prevent & Control, Dis Programmes Unit, Stockholm, Sweden. | - |
local.description.affiliation | [Molenberghs, Geert] Katholieke Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat I BIOST, Leuven, Belgium. | - |
local.uhasselt.international | yes | - |
item.validation | ecoom 2022 | - |
item.contributor | Adriaenssens, Niels | - |
item.contributor | BRUYNDONCKX, Robin | - |
item.contributor | Versporten, Ann | - |
item.contributor | HENS, Niel | - |
item.contributor | Monnet, Dominique L. | - |
item.contributor | MOLENBERGHS, Geert | - |
item.contributor | Goossens, Herman | - |
item.contributor | Weist, Klaus | - |
item.contributor | Coenen, Samuel | - |
item.accessRights | Open Access | - |
item.fullcitation | Adriaenssens, Niels; BRUYNDONCKX, Robin; Versporten, Ann; HENS, Niel; Monnet, Dominique L.; MOLENBERGHS, Geert; Goossens, Herman; Weist, Klaus & Coenen, Samuel (2021) Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017. In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (Supplement_2) , p. 37 -44. | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 0305-7453 | - |
crisitem.journal.eissn | 1460-2091 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
dkab176.pdf | Published version | 552.68 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
19
checked on Apr 30, 2024
Page view(s)
44
checked on Sep 7, 2022
Download(s)
22
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.